Abstract
A 64-year-old female with a background of type 2 diabetes became acutely unwell after being transferred from insulin to liraglutide, which is one of the new glucagon like peptide 1 analogues. On assessment in accident and emergency, she was diagnosed with diabetic ketoacidosis and pancreatits. Glutamic acid decarboxylase antibodies were positive at 45 (0-1 U/ml) and C-peptide was low <94 pmol/l in keeping with the diagnosis of latent autoimmune diabetes of adults (LADA). This type of diabetes is characterised by slow autoimmune destruction of β cells of pancreas and can often be mistaken for type 2 diabetes. Patients suffering from LADA or type 1 and 1/2 diabetes require insulin to prevent ketoacidosis. She recovered with insulin treatment. Copyright 2011 BMJ Publishing Group. All rights reserved.
Cite
CITATION STYLE
Gooderick, D., Dashora, U., & Kumar, S. (2011). Ketoacidosis in type 2 diabetes- is it type 1 and 1/2 diabetes? BMJ Case Reports. https://doi.org/10.1136/bcr.07.2011.4460
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.